trending Market Intelligence /marketintelligence/en/news-insights/trending/fPIlfIYd8_JW5o0MjDiCGA2 content esgSubNav
In This List

West Pharmaceutical raises stake in Daikyo Seiko to 49%

Blog

Insight Weekly: Private equity slows; SPAC underwriters retreat; carbon capture boost

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms


West Pharmaceutical raises stake in Daikyo Seiko to 49%

West Pharmaceutical Services Inc. said it increased its minority equity stake in Japan-based Daikyo Seiko, Ltd. to 49%.

Exton, Pa.-based West Pharmaceutical manufactures and sells containment and delivery systems for injectable drugs and healthcare products, while Daikyo manufactures pharmaceutical packaging and medical device components.

Both companies have been partners for over 40 years and West Pharmaceutical exclusively distributes and markets Daikyo's products globally. The partnership also includes a technology exchange and cross-license agreement. Additionally, Daikyo distributes West Pharmaceutical's products within Japan.